Pregnancy outcomes in COVID positive patients

https://doi.org/10.53730/ijhs.v6nS1.4979

Authors

  • J. V. Shukla Associate Professor, Dept. of Obstetrics and Gynecology, Dhiraj Hospital, Smt. BK Shah Medical Institute & Research Centre, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara 391760, Gujarat, India
  • Piyusha Chandrayan Associate Professor, Dept. of Obstetrics and Gynecology, Dhiraj Hospital, Smt. BK Shah Medical Institute & Research Centre, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara 391760, Gujarat, India
  • Shah Harvy Nigam 2nd year resident, Dept. of Obstetrics and Gynecology, Dhiraj Hospital, Smt. BK Shah Medical Institute & Research Centre, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara 391760, Gujarat, India
  • Dhrumil A. Shah 3rd year resident, Dept. of Obstetrics and Gynecology, Dhiraj Hospital, Smt. BK Shah Medical Institute & Research Centre, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara 391760, Gujarat, India
  • Isha M. Shah 2nd year MBBS student, GMERS Medical College, Gotri, Vadodara-390021, Gujarat, India
  • Manish R. Shah Associate Professor, Dept. of Orthopaedics, Dhiraj Hospital, Smt. BK Shah Medical Institute & Research Centre, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara 391760 Gujarat India

Keywords:

COVID-19, fetus-maternal outcome, positive patients, pregnancy, vertical transmission

Abstract

Background and Objective: A new pathogen of high contagious abilities named Corona virus was seen to target pregnant women due to physiologic changes in their immune system, cardiopulmonary and coagulation system leading to poor fetus-maternal outcome. Thus, to determine maternal and fetal outcome in pregnant women affected with COVID-19 and its frequency of vertical transmission is the main objective of the study. Methods: This is a prospective study of 50 pregnant women with RTPCR confirmed COVID-19 infection between 1st March 2021 and 1st August 2021. The foetal and maternal outcome, frequency of vertical transmission, mode of delivery, presenting symptoms and Level of serum markers such as LDH and CRP were noted. Results: Among 50 patients, 68% delivered through Caesarean section 34% delivered vaginally. The most common presenting symptom was fever in 50% patients. Other symptoms were running nose, headache, myalgia, loss of smell and taste.68% patients had raised Serum LDH level and 26% patient had raised Serum CRP level. The maternal condition was taken into account based on source of oxygen saturation by monitoring Spo2 level.

Downloads

Download data is not yet available.

References

World Health Organization. Coronavirus disease (COVID-19) pandemic. Available online at:

https://www.who.int/emergencies/diseases/novel- Corona virus -2019t. Last accessed on February 17, 2020).

Alserehi H, Wah G, Alshukairi A, Alraddadi B. Impact of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016; 16(5): 105-10.

Lam CM, Wong SF, Leung TN, Chow KM, Yu WC, Wong TY, et al. A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. BJOG. 2004; 111 (8): 771-4.

Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature. J Microbiology Immunology Infect. 2019; 52 (3): 501-3.

Huang C, Wang Y, Li X, Ren Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novelCoronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506.

6 . Jeong SY, Sung SI, Sung J, Ahn SY, Kang ES, Chang YS, et al. MERS-CoV infection in a pregnant woman in Korea.J Korean Med Sci. 2017; 32 (10): 1717-20.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-13.

Chen S, Huang B, Luo DJ, Li X, Yang F, Zhao Y, et al.

Pregnant women with new Coronavirus infection: a clinical characteristics and placental pathological analysis of three cases. Zhonghua Bing Li XueZaZhi.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine verticaltransmission potential ofCOVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020: 395 r102261: 809-15.

Schwartz DA. An analysis of 38 pregnant women with 2 COVID-19, their newborn infants, and maternal fetal transmission of SARS-CoV-2: maternal Coronavirus infections and pregnancy

outcomes. Arch Pathology Lab Med. 2020; 5858/arpa.2020-0901-5A.

11 .ZenX H, Xu C. Fan J, et al. Antibodies in in-fonts born to mothers with COVID- 1 9 pneumonia. JAMA 20ÿ32 3(IS):1845-9.

12. Done L, Tian J. Hc S, Zhu C, Wane J. Liu C. el al. Possible vertical transmission of SARSCov- 2 from an injected mother tohernewborn. JAMA 2020

13. World Health Organization. Frequently askedquestions: Breast-feeding and Covid 19 dated 12 may 2020. Available at https://www.who.int/docs/default-source/maternal-health/faqs-breastfeeding-and-covid-19.pdf?sfvrsn=d839e6c0_5. Accessed on 10th June 2020

Published

23-03-2022

How to Cite

Shukla, J. V., Chandrayan, P., Nigam, S. H., Shah, D. A., Shah, I. M., & Shah, M. R. (2022). Pregnancy outcomes in COVID positive patients. International Journal of Health Sciences, 6(S1), 2013–2020. https://doi.org/10.53730/ijhs.v6nS1.4979

Issue

Section

Peer Review Articles